28.08.2026 Dis-Chem succession enters a new phase The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now. This article is for Health Matters subscribers Subscribers read every article in full, receive the daily briefing and have access to the complete archive. SubscribeLog in Dis-Chem; Ivan Saltzman; Rui Morais; private healthcare; pharmacy retail; healthcare investment